EUVIMEDEUVIMED entdecken
Crossref

Radiolabeling and Preclinical Evaluation of 2-[ 18 F]Fluorohexanoic Acid: A Novel Medium-Chain Fatty Acid Metabolism Tracer for PET Imaging of Tumors

Guolin Wang, Qianhe Xu, Shuyi Zhang, Ying Han, Xili Lu, Xuefen Li, Xinhui Su iD, Zhenfeng Liu iD

Journal of Medicinal Chemistry · 2025

DOI: 10.1021/acs.jmedchem.5c00535 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Medicinal Chemistry, 2025. Verfasst von Guolin Wang und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Nuclear Medicine, the First Affiliated Hospital, Zhejiang University School of Medicine, 79 Qingchun Road, Hangzhou 310003, China. Hauptthemen laut MEDLINE: Positron-Emission Tomography, Fluorine Radioisotopes, Radiopharmaceuticals, Fatty Acids. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 39 Literaturangaben. Gefördert von: Medical Science and Technology Project of Zhejiang Province, Natural Science Foundation of Zhejiang Province.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Fatty acid metabolism plays a critical role in cancer development. In this study, a novel medium-chain fatty acid (MCFA) PET tracer, 2-[ 18 F]fluorohexanoic acid ( 18 F-FHA), was successfully synthesized with high radiochemical yield (65 ± 5.4%) and purity (>99%). Tumor radiotracer uptake at 60 min in A431, Hek293, Kpc, 4T1, Hep3b, and Lm3 xenograft models was 7.1 ± 0.4, 8.8 ± 0.6, 7.7 ± 0.5, 7.2 ± 0.4, 5.1 ± 0.3, and 4.9 ± 0.3 percentage injected dose per gram (% ID/g), respectively. Pretreatment with salicylic acid (SA), an inhibitor of medium-chain acyl-CoA synthetase (ACSM), significantly enhanced tumor uptake ( p < 0.05) but showed no effect on blood uptake ( p = 0.115). The biodistribution analysis demonstrated that 18 F-FHA exhibited rapid hepatic and cardiac accumulation followed by gradual clearance, whereas tumor uptake exhibited gradual elevation within the initial 20 min and remained relatively stable through the 90 min observation period. 18 F-FHA warranted further investigation as a potential PET imaging agent for tumors.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Positron-Emission TomographyFluorine RadioisotopesRadiopharmaceuticalsFatty AcidsNeoplasmsCaproatesAnimalsHumansTissue DistributionMiceCell Line, TumorFemaleMice, NudeMice, Inbred BALB C

Substanzen

Fluorine RadioisotopesRadiopharmaceuticalsFatty AcidsCaproates

Autor:innen und Institutionen

  • Department of Nuclear Medicine, the First Affiliated Hospital, Zhejiang University School of Medicine, 79 Qingchun Road, Hangzhou 310003, China.
  • Department of Laboratory Medicine, Key Laboratory of Clinical In Vitro Diagnostic Techniques of Zhejiang Province, the First Affiliated Hospital, Zhejiang University School of Medicine, 79 Qingchun Road, Hangzhou 310003…

ORCID-Profile: Xinhui Su, Zhenfeng Liu

Förderung

  • Medical Science and Technology Project of Zhejiang Province
  • Natural Science Foundation of Zhejiang Province

Zitieren

APA

Wang, G., Xu, Q., Zhang, S., Han, Y., Lu, X., Li, X., Su, X., & Liu, Z. (2025). Radiolabeling and Preclinical Evaluation of 2-[ 18 F]Fluorohexanoic Acid: A Novel Medium-Chain Fatty Acid Metabolism Tracer for PET Imaging of Tumors. Journal of Medicinal Chemistry. https://doi.org/10.1021/acs.jmedchem.5c00535

Vancouver

Wang G, Xu Q, Zhang S, Han Y, Lu X, Li X, et al. Radiolabeling and Preclinical Evaluation of 2-[ 18 F]Fluorohexanoic Acid: A Novel Medium-Chain Fatty Acid Metabolism Tracer for PET Imaging of Tumors. Journal of Medicinal Chemistry. 2025. doi:10.1021/acs.jmedchem.5c00535

BibTeX
@article{Wang2025,
  author = {Wang, Guolin and Xu, Qianhe and Zhang, Shuyi and Han, Ying and Lu, Xili and Li, Xuefen and Su, Xinhui and Liu, Zhenfeng},
  title = {Radiolabeling and Preclinical Evaluation of 2-[ 18 F]Fluorohexanoic Acid: A Novel Medium-Chain Fatty Acid Metabolism Tracer for PET Imaging of Tumors},
  journal = {Journal of Medicinal Chemistry},
  year = {2025},
  doi = {10.1021/acs.jmedchem.5c00535}
}
Kostenlos starten →